Back to search
Adult-Onset Still Disease
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Adult-Onset Still Disease trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Adult-Onset Still Disease trials you may qualify forThe study is a phase II trial designed to evaluate the clinical efficacy, safety, and tolerability of MAS825 in pediatric and adult participants with Still's di…
Background: Inflammatory conditions can cause symptoms like fevers, arthritis, and rash. Systemic juvenile idiopathic arthritis (sJIA) is one of these conditio…
The purpose of this study is to compare the efficacy and safety of firsekibart versus anakinra in patients with AOSD.
To facilitate clinical, basic science, and translational research projects involving the study of rheumatic diseases.
Adult Onset Still Disease (AOSD) and Systemic onset Juvenile Idiopathic Arthritis (SoJIA) are two rare multifactorial diseases associated with systemic inflamma…
In healthy subjects, from 50 to 80 % of the serum ferritin is glycosylated \[1, 2\] . A decrease in the percentage of ferritin glycosylation can be observed in…
This study aims to assess and characterize the treatment patterns, and long-term clinical outcomes and demographic characteristics of patients diagnosed with Fa…
This study was designed to evaluate the efficacy and safety of canakinumab administered subcutaneously every 4 weeks for at least 48 weeks in Japanese patients…
Assessment of macrophage activation syndrome in Still's disease: retrospective chart analysis of patient history, symptom resolution and treatment characterist…